Iomeron
Active substance: iomeprol
INJECTION, SOLUTION · IOMEPROL 612 mg/mL
United StatesActive
Marketing holder: BIPSO GmbH
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- IOMEPROL · 612 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-8fc5-70a6-ad90-3b78df35c5c1,01a1208c-d3e4-76af-8e0c-b3da42c6dd24,01a1208c-d3e5-76e5-913f-bdd2e2a82749,01a1208d-69e7-7dd9-bcc2-5b7d039e8943,01a1208d-69fa-7471-b146-006035f2eb6a;count=16 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 76381-930
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVASCULAR
Sources
- product · openFDA NDC · 76381-930 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 76381-930 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 76381-930 · Verified 2026-10-09 · open in source